Search research articles
Contact Us
Filters
Showing results (451-460 of 478) with videos related to
Page
of 48
Sort By:
The American Journal of Dermatopathology
|
August 1, 1997
CD56/neural cell adhesion molecule expression in primary extranodal Ki-1/CD30+ lymphoma. Report of a pediatric case with simultaneous cutaneous and bone localizations
M Paulli, E Boveri, R Rosso, et al.
Cancer
|
August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)
H S Parra, L Tixi, F Latteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2001
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients
L Del Mastro, M Venturini, C Viscoli, et al.
British Journal of Cancer
|
July 17, 1999
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
N Thatcher, E S De Campos, D R Bell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study
U Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Tumori
|
July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force
F De Marinis, M Rinaldi, A Ardizzoni, et al.
Human Pathology
|
November 21, 1998
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily
M Paulli, E Berti, E Boveri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
M E R O'Brien, N Wigler, M Inbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 12, 2005
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
A De Paoli, S Chiara, G Luppi, et al.
American Journal of Clinical Oncology
|
February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study
A Ardizzoni, G Antonelli, S Ricci, et al.
Page
of 48
Search research articles
Search
Showing results (451-460 of 478) with videos related to
Sort By:
Page
of 48
The American Journal of Dermatopathology
|
August 1, 1997
CD56/neural cell adhesion molecule expression in primary extranodal Ki-1/CD30+ lymphoma. Report of a pediatric case with simultaneous cutaneous and bone localizations
M Paulli, E Boveri, R Rosso, et al.
Cancer
|
August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)
H S Parra, L Tixi, F Latteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2001
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients
L Del Mastro, M Venturini, C Viscoli, et al.
British Journal of Cancer
|
July 17, 1999
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
N Thatcher, E S De Campos, D R Bell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study
U Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Tumori
|
July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force
F De Marinis, M Rinaldi, A Ardizzoni, et al.
Human Pathology
|
November 21, 1998
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily
M Paulli, E Berti, E Boveri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
M E R O'Brien, N Wigler, M Inbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 12, 2005
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
A De Paoli, S Chiara, G Luppi, et al.
American Journal of Clinical Oncology
|
February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study
A Ardizzoni, G Antonelli, S Ricci, et al.
Page
of 48